Vipergen

Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only company capable of screening DELs inside a living cell. Vipergen provides its proprietary suite of leading-edge DEL technologies as a service to biotechnology and pharmaceutical company partners, including top pharmaceutical companies in the US, EU, and Japan. For more details about Vipergen and the YoctoReactor®, Binder Trap Enrichment®, and Cellular Binder Trap Enrichment® drug discovery technology platforms, please visit www.vipergen.com.